✦ LIBER ✦

PCN86 A Q-TWIST ANALYSIS COMPARING PANITUMUMAB PLUS BEST SUPPORTIVE CARE (BSC) WITH BSC ALONE IN PATIENTS WITH WILD-TYPE KRAS METASTATIC COLORECTAL CANCER

✍ Scribed by J. Wang; Z. Zhao; B. Sherrill; M. Peeters; J. Wiezorek; B. Barber

Book ID: 119309697
Publisher: John Wiley and Sons
Year: 2011
Tongue: English
Weight: 55 KB
Volume: 14
Category: Article
ISSN: 1098-3015
DOI: 10.1016/j.jval.2011.02.941

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A Q-TWiST analysis comparing panitumumab

A Q-TWiST analysis comparing panitumumab plus best supportive care (BSC) with BSC alone in patients with wild-type KRAS metastatic colorectal cancer

✍ Wang, J; Zhao, Z; Barber, B; Sherrill, B; Peeters, M; Wiezorek, J 📂 Article 📅 2011 🏛 Nature Publishing Group 🌐 English ⚖ 368 KB

PCN64 The Cost Effectiveness of Cetuxima

PCN64 The Cost Effectiveness of Cetuximab Plus Best Supportive Care (BSC) Versus BSC Alone in Last Line for KRAS Wild Type Metastatic Colorectal Cancer Patient Population

✍ Chaugule, S.; Hay, J. 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 60 KB

Open-Label Phase III Trial of Panitumuma

Open-Label Phase III Trial of Panitumumab Plus Best Supportive Care Compared With Best Supportive Care Alone in Patients With Chemotherapy-Refractory Metastatic Colorectal Cancer

✍ Van Cutsem, E.; Peeters, M.; Siena, S.; Humblet, Y.; Hendlisz, A.; Neyns, B.; Ca 📂 Article 📅 2007 🏛 American Society of Clinical Oncology 🌐 English ⚖ 280 KB

6005 ORAL A Multicenter, Randomized, Dou

6005 ORAL A Multicenter, Randomized, Double-blind, Phase II Study of TAS-102 (A) Plus Best Supportive Care (BSC) Versus Placebo (P) Plus BSC in Patients (pts) With Chemotherapy-refractory Metastatic Colorectal Cancer (mCRC)

✍ Kuboki, Y.; Yoshino, T.; Yamazaki, K.; Nishina, T.; Komatsu, Y.; Baba, H.; Tsuji 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 42 KB

6132 POSTER Efficacy of Panitumumab Plus

6132 POSTER Efficacy of Panitumumab Plus FOLFIRI Versus FOLFIRI Alone in Patients With Wild-Type (WT) KRas Metastatic Colorectal Cancer (mCRC) Treated With Prior Oxaliplatin or Bevacizumab Regimens: Results From 20050181

✍ Price, T.; Peeters, M.; Strickland, A.; Ciuleanu, T.E.; Scheithauer, W.; O'Reill 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 61 KB